)
Vor Biopharma (VOR) investor relations material
Vor Biopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of two Class II director nominees, Andrew Levin and Fouad Namouni, each for a three-year term expiring at the 2029 annual meeting and until a successor is duly elected and qualified.
Approval of the amendment and restatement of the 2021 Equity Incentive Plan is proposed.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends a vote in favor of all director nominees and the listed proposals.
Audit committee and external auditor matters
Audit committee has selected Ernst & Young LLP as the independent auditor for the upcoming fiscal year.
- Biotech registers 5.3M shares for resale after $75M private placement to fund autoimmune drug trials.VOR
Registration filing27 Apr 2026 - Virtual meeting to elect directors, amend equity plan, and ratify auditor, with strong governance focus.VOR
Proxy filing27 Apr 2026 - Global Phase 3 trials for telitacicept advance, with strong cash runway and major financial swings.VOR
Q4 202530 Mar 2026 - Telitacicept delivers robust, durable efficacy and safety in major autoimmune diseases, enabling global expansion.VOR
Corporate presentation9 Mar 2026 - Telitacicept advances in late-stage trials for MG and Sjögren's, targeting major autoimmune markets.VOR
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Gene-edited stem cell transplants for AML show strong early results and pivotal trial progress.VOR
Oppenheimer 35th Annual Healthcare Life Sciences Conference 20253 Feb 2026 - 13.9M shares registered for resale after $150M private placement; no proceeds to the company.VOR
Registration Filing29 Jan 2026 - Trem-cel with Mylotarg yields rapid engraftment and promising RFS in high-risk AML.VOR
Study Update22 Jan 2026 - Telitacicept advances in global Phase 3 trials for MG and Sjögren's, backed by strong data and funding.VOR
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026
Next Vor Biopharma earnings date
Next Vor Biopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)